Table Of Contents

01 *Methodology and Scope

1.1 Market Segmentation & Scope
1.1.1 Product Type
1.1.2 Regional Scope
1.1.3 Estimates and Forecast Timeline
1.3 Information Procurement
1.3.1 Secondary Sources
1.3.2 Details of Primary Research
1.4 List of Abbreviations

02 Executive Summary

2.1 Market Outlook
2.2 Segment Outlook

03 Asia Pacific Interventional Cardiology Devices Market: Variables, Trends, & Scope

3.1 Asia Pacific Interventional Cardiology Devices Market: Key Market Development
3.2 Penetration & Growth Prospect Mapping
3.3 APAC Value Chain Analysis
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Growing Geriatric Population and Healthcare Spending
3.4.1.2 Increased Prevalence of Cardiovascular Disease
3.4.1.3 Growing Number of Cardiac Catherization Labs
3.4.2 Market Restraint Analysis
3.4.2.1 Procedures volumes are down due to COVID19
3.5 Asia Pacific Interventional Cardiology Devices Market Analysis Tools
3.5.1 Porter's Five Forces Analysis

3.5.2 Pestel Analysis

04 Asia Pacific Interventional Cardiology Devices Market: Product Type Segment Analysis

4.1 Asia Pacific Interventional Cardiology Devices: Market Share Analysis, 2020 & 2027
4.1.1 Interventional Cardiology Devices
4.1.1.1 Stents
4.1.1.1.1 Stents market, 2020-2027 (USD Million)
4.1.1.2 Interventional Catheters
4.1.1.3 PTCA Guidewires
4.1.1.3.1 PTCA Guidewires market, 2020-2027 (USD Million)
4.1.1.4 PTCA Balloons
4.1.1.4.1 PTCA Balloons market, 2020-2027 (USD Million)
4.1.1.5 Balloon Inflation Device
4.1.1.5.1 Balloon Inflation Device market, 2020-2027 (USD Million)
4.1.1.6 Cardiac Valve
4.1.1.6.1 Cardiac Valve Device market, 2020-2027 (USD Million)

05 Asia Pacific Interventional Cardiology Devices Market: Country Level Analysis

5.1 Asia Pacific Interventional Cardiology Devices: Regional Market Share
5.2 Asia Pacific Interventional Cardiology Devices: Market Share Analysis, 2020 & 2027
5.3 Asia Pacific
5.3.1 Asia Pacific Interventional Cardiology Devices Market, 2020 - 2027 (USD BILLION)
5.3.2 INDIA
5.3.2.1 India Interventional Cardiology Devices market, 2020 - 2027 (USD Million)
5.3.2.2 India SWOT Analysis
5.3.3 JAPAN
5.3.3.1 Japan Interventional Cardiology Devices market, 2020 - 2027 (USD Million)
5.3.3.2 Japan SWOT Analysis
5.3.4 CHINA
5.3.4.1 China Interventional Cardiology Devices market, 2020 - 2027 (USD Million)
5.3.4.2 China SWOT Analysis
5.3.5 SOUTH KOREA
5.3.5.1 South Korea Interventional Cardiology Devices market, 2020 - 2027 (USD Million)
5.3.5.2 South Korea SWOT Analysis

06 Company Profiles

6.1 BOSTON SCIENTIFIC
6.1.1 Company overview
6.1.2 Financial performance
6.1.3 Product benchmarking
6.1.4 Strategic initiatives
6.2 MEDTRONIC
6.2.1 Company overview
6.2.2 Financial performance
6.2.3 Product benchmarking
6.2.4 Strategic initiatives
6.3 ABBOTT
6.3.1 Company overview
6.3.2 Financial performance
6.3.3 Product benchmarking
6.3.4 Strategic initiatives
6.4 NORDSON MEDICAL
6.4.1 Company overview
6.4.2 Financial performance
6.4.3 Product benchmarking
6.4.4 Strategic initiatives
6.5 TERUMO CORPORATION
6.5.1 Company overview
6.5.2 Financial performance
6.5.3 Product benchmarking
6.5.4 Strategic initiatives
6.6 COOK GROUP
6.6.1 Company overview
6.6.2 Financial performance
6.6.3 Product benchmarking
6.6.4 Strategic initiatives
6.7 STENTYS SA
6.7.1 Company overview
6.7.2 Financial performance
6.7.3 Product benchmarking
6.7.4 Strategic initiatives

07 KOL Commentary- Primary Research Insights​

7.1 KOREA
7.2 INDIA
7.3 CHINA
7.4 JAPAN

Research Methodology

Our research methodology entails an ideal mixture of primary and secondary initiatives. Key steps involves in the process are listed below:

• Information procurement
  This stage involves procurement of market data or related information via different sources & methodologies.
• Information analysis
  This step involves the analysis & mapping of all the information procured from the previous step. It also encompasses analysis of data discrepancies observed across various data sources.
• Market formulation
  The final step entails approximation of data points in an attempt to deduce viable conclusions. Analyst perspective & subject-matter-expert–based heuristic form of market sizing also plays an integral role in this step.
• Validation & publishing
  Validation is the most important step in the process. Validation & revalidation via an intricately designed process helps us finalize data points to be used for final calculations.

01. Information Procurement

1.1 Secondary Sources

• A list of secondary sources along with the information extracted from them will be available in the final deliverable
• Notable examples include white papers and government statistics published by organizations such as WHO, NGOs, World Bank, etc.; KOL publications; company filings; investor documents; and others
• Third-party perspective includes market derivation through investor analysts’ report, broker reports, academic commentary, and government quotes & wealth management publications.

1.2 Details Of Primary Research

Primary interviews were conducted based on a predetermined sample size. The sample included a mix of industry experts and end users. Following participants were included in discussion:

• Industry experts/KOLs
• Providers
• Academician

1.2 Information or Data Analysis

Information procured from secondary and primary initiatives are then analyzed by using the following tools/models (a partial list):

• Identifying variables and establishing market impact
• Establishing market trends
• Analyzing future opportunities and market penetration rates by understanding product commercialization, regional expansion, etc.
• Analyzing reimbursement/regulatory trends and changes in market dynamics to establish future growth potential
• Analyzing sustainability strategies adhered by market participants in an attempt to determine future course of the market
• Analyzing historical market trends and superimposing them on the current and future variables to determine year-on-year trends
• Understanding consumer base, procedure trends, and regulatory framework
• Keeping a track of technological advancements in individual segments
• Base numbers are established by analyzing the following:
• Company revenue and market share (this list generally includes the analysis of revenue published by publicly listed manufacturers)
• Derivation of market estimates through analysis of parent markets (bottom-up approach)

1.3 Data Analysis Models

• Model selection: Demand based bottom-up approach and usage rate-based approach
• Penetration modeling for products
• Determining and forecasting penetration via analyzing product features, proposed pricing, availability of internal and external substitutes etc.
• Heuristic estimation of year-on-year sales by conducting primary interviews with:
• Healthcare practitioners
• Industry experts & KoLs
• Distributors o Product sizing and forecasting by following a diffusion model based on S-curve growth
• Analysis of current usage rates and patterns to determine substitution rates
• Identifying variables and assigning impact to determine growth)
• Referring to historic data to establish base estimates
• User size-based penetration
• Analyzing current needs and determining penetration to estimate market size or sales
• Using unmet needs and capitalization rates to determine growth
• Trend analysis (based on year-on-year trending models)